Susman Godfrey's Cycling Team "Swift Justice" Rides to Fight Multiple Sclerosis

Apr 13, 2011, 14:08 ET from Susman Godfrey L.L.P.

HOUSTON, April 13, 2011 /PRNewswire/ -- This weekend on April 16-17, 2011, 38 partners, associates, staff, family and friends of Susman Godfrey L.L.P. will ride 180 miles from Houston to Austin as part of the BP MS150.   Team Susman Godfrey will field newly designed jerseys sporting its new motto "Swift Justice."


Team Susman Godfrey first rode in this event two years ago with 11 riders.  Last year, the team doubled in size to 22 riders.  This year, the team has almost doubled again.  Riders include lawyers from four of the firm's offices  -- Seattle, New York, Dallas, and Houston.  

The team is led by Team Captain Trey Peacock who is in his sixth year of riding this event.  Explaining his motivation for doing this each year, Peacock said, "When you think about the fight that thousands of folks with multiple sclerosis face each and every day, what we do for two days in April riding beautiful Texas roads to Austin is just a small task that we can perform to hopefully make their lifelong fight a bit easier."  

Leading the pack as the team heads to Austin is the firm's leader Steve Susman, who first rode this event last year.  As the team's oldest rider, Susman commented, "I decided to do this at age 70 in order to emphasize to my teammates the importance of finding a cure for multiple sclerosis. We can at least use our being blessed with good health to help others who are not."  To meet that goal, the team's 38 riders have been actively working their donor contacts.  The team is aiming to raise $60,000 and is already 75% of the way there.  This year's team also includes two of the top 300 fundraisers from last year's BP MS150 ride—Jonathan Ross and Trey Peacock.  

Organized by the Lone Star Chapter of the National Multiple Sclerosis Society, the BP MS150 is the largest MS150 ride in the nation with over 12,000 riders.  This year's BP MS150 is expected to raise over $17,000,000 to fund research and treatment for this dreaded disease.

SOURCE Susman Godfrey L.L.P.